Pharmaceutical Technology of Modified Drug Release

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2022-2023

Lehrbeauftragte/r

  • Dr. Szilárd PÁL

    assistant professor,
    Institute of Pharmaceutical Technology and Biopharmacy

Semesterwochenstunden

Vorlesungen: 14

Praktika: 0

Seminare: 0

Insgesamt: 14

Fachangaben

  • Kode des Kurses: OTF-MGT-T
  • 1 kredit
  • Biotechnology BSc
  • Optional modul
  • spring
Voraussetzungen:

OTM-PMBT-T completed

Zahl der Kursteilnehmer für den Kurs:

min. 1 – max. 50

Thematik

Students can get acquainted in details with modified drug delivery technologies and special industrial drug manufacture (3D printing, manufacture of multi-layer tablets and osmotic preparations) and the importance of pharmaceutical excipients. Student will learn special manufacturing technologies through the demonstration of dosage forms already available in the pharmaceutical therapy.

Vorlesungen

  • 1. Theory of modified drug release - Dr. Pál Szilárd
  • 2. Importance of excipients, patents of excipient-compositions - Dr. Kása Péter
  • 3. Immediate drug-release (OraSolv, DuraSolv, Zydis technology) - Dr. Pál Szilárd
  • 4. Sustained drug-release: Multiparticulate dosage forms I. (sustained release pellets in practice) - Dr. Pál Szilárd
  • 5. Multiparticulate dosage forms II. (MUPS technology) - Dr. Pál Szilárd
  • 6. Matrix systems I. (hydrophilic matrices) - Dr. Pál Szilárd
  • 7. Matrix systems II. (hydrophobic matrices) - Dr. Pál Szilárd
  • 8. Osmotic technology (EOP, OROS, L-OROS, GITS) - Dr. Pál Szilárd
  • 9. Geometry based drug-release (Geomatrix, Procise, Smartrix technology) - Dr. Kása Péter
  • 10. Chronotherapeutic systems (Geoclock technology) - Dr. Pál Szilárd
  • 11. 3D printing in the field of modified drug delivery - Dr. Pál Szilárd
  • 12. Site specific drug release (gastroretentive systems, colon-specific drug delivery) - Dr. Pál Szilárd
  • 13. Halving of tablets, technology of halving-friendly tablets, concept of ,,ghost" tablets - Dr. Kása Péter
  • 14. End-year test - Dr. Pál Szilárd

Praktika

Seminare

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

Vom Institut veröffentlichter Lehrstoff

Skript

Empfohlene Literatur

James Swarbrick: Encyclopedia of Pharmaceutical Technology, Informa Healthcare, 2011

Voraussetzung zum Absolvieren des Semesters

Maximum of 25 % absence allowed

Semesteranforderungen

During the end semester test 60 % should be reached.

Möglichkeiten zur Nachholung der Fehlzeiten

According to the Code of Studies and Examinations

Prüfungsfragen

http://gytk.pte.hu

Prüfer

Praktika, Seminarleiter/innen

  • Dr. Kása Péter
  • Dr. Pál Szilárd